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This perspective aims to highlight the lack of current knowledge on sarcopenic obesity
in Africa and to call for diagnostic methods and appropriate interventions. Sarcopenic
obesity has been defined as obesity that occurs in combination with low muscle
mass and function, which is typically evident in older adults. However, there has been
no clear consensus on population-specific diagnostic criterion, which includes both
gold-standard measures that can be used in a more advanced health care system,
and surrogate measures that can be used in low-income settings with limited resources
and funding. Importantly, low and middle-income countries (LMICs) across Africa are
in an ongoing state of economic and social transition, which has contributed to an
increase in the aging population, alongside the added burden of poverty, obesity, and
associated co-morbidities. It is anticipated that alongside the increased prevalence of
obesity, these countries will further experience an increase in age-relatedmusculoskeletal
diseases such as sarcopenia. The developmental origins of health and disease (DOHaD)
approach will allow clinicians and researchers to consider developmental trajectories,
and the influence of the environment, for targeting high-risk individuals and communities
for treatment and/or prevention-based interventions that are implemented throughout all
stages of the life course. Once a valid and reliable diagnostic criterion is developed, we
can firstly assess the prevalence and burden of sarcopenic obesity in LMICs in Africa,
and secondly, develop appropriate and sustainable interventions that target improved
dietary and physical activity behaviors throughout the life course.
Keywords: sarcopenia, skeletal muscle, quality of life, aging, muscle function, muscle quality, low and
middle-income countries
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INTRODUCTION
This perspective aims to highlight the lack of current knowledge
on sarcopenic obesity in Africa and to call for diagnostic methods
and appropriate interventions. Importantly, due to increasing
urbanization as well as the effective treatment of infectious
diseases such as HIV, people in Africa are living longer but
presenting with disability and ill health, resulting in an increased
burden on family, community and the health care system (1).
Increased longevity and the changes in lifestyle behaviors that
occur with urbanization, are associated with an increased risk
of developing obesity and age-related musculoskeletal diseases
such as sarcopenia and osteoporosis (2). Sarcopenia alone
contributes to poor health outcomes and frailty in older adults.
When sarcopenia occurs in conjunction with obesity, termed
“sarcopenic obesity,” it can have further health and functional
implications that reduce quality of life and increase overall
mortality (3–6) to a greater extent than either condition in
isolation (7–10). However, there is a lack of evidence concerning
both the prevalence and the burden of sarcopenia and sarcopenic
obesity in Africa. It is also unclear as to whether the current
diagnostic criteria for these conditions are appropriate for use in
African populations. There is a large variability in the prevalence
of sarcopenic obesity across LMICs, with India, Ghana, Mexico
and South Africa reporting a prevalence of 1.3, 5.4, 10.2, and
10.3%, respectively (11). Although we focus on an African
perspective it is hypothesized that the variable prevalence rates
reported in the literature may have been significantly influenced
by a lack of research and population-specific diagnostic criteria
across all LMICs.
OBESITY AND SARCOPENIA AS
COMORBID CONDITIONS
Few studies have considered sarcopenia and obesity as comorbid
conditions in Africa (11). It is well-established that the aging
process stimulates mechanisms resulting in the attenuation of
muscle quality (strength or power normalized to muscle size)
and muscle mass (12). These mechanisms include reductions in
muscle fiber size, fiber number, mitochondrial dysfunction, and
contractile function, and increases in ectopic fat accumulation
and inflammation within the skeletal muscle (12–15). When age-
related loss in muscle quality and quantity occur simultaneously
with obesity these mechanisms are amplified and the result is
sarcopenic obesity (12). There are also complex interactions
between lifestyle behaviors, such as dietary intake and physical
activity, and the aging process. All of these collectively contribute
to reduced muscle quality, muscle quantity and metabolic health
[further explored by (16)].
LMICs across Africa are in an ongoing state of economic
and social transition, which has contributed to an increase in
the aging population, alongside the added burden of poverty,
obesity, and associated co-morbidities (17, 18). Increasing
urbanization is also accompanied by a reduction in levels of
physical activity, increased sedentary behavior and nutritional
deficiencies (19–21). These may occur throughout the life
course, and act as risk factors for sarcopenic obesity (15,
22, 23). For example, nutritional deficiency alongside obesity
has created a double burden of malnutrition in Africa.
Wasting and stunting during early growth and development
predisposes individuals to obesity during adulthood (24, 25),
potentially placing them at greater risk for the development
of sarcopenic obesity as an older adult. Accordingly, we
suggest that it is important to consider early life influences,
as well as current lifestyle behaviors, to better understand
and potentially prevent or mitigate sarcopenic obesity (26, 27)
in these settings. The DOHaD approach will allow clinicians
and researchers to consider developmental and environmental
history for targeting high-risk individuals and communities
for treatment and/or prevention-based interventions that can
be implemented throughout all stages of the life course.
However, the implementation of interventions in Africa are often
constrained by limited resources. We urge the research and
public health communities to advise on innovative strategies that
target lifestyle-related opportunities throughout the life course.
Most notably, these strategies need to be co-designed with the
communities in which these interventions will be implemented
to ensure uptake and sustainability. Interventions and public
health initiatives can be subsequently designed to simultaneously
target nutritional deprivation, physical inactivity, and obesity
throughout the life course in high-risk communities, with the
overall aim of preventing sarcopenia, sarcopenic obesity, and
associated co-morbidities.
BEGIN WITH THE END IN MIND:
CLASSIFICATION OF SARCOPENIA AND
SARCOPENIC OBESITY
In order to focus on sarcopenic obesity within Africa, it is
important to ensure that there are appropriate, population-
specific diagnostic criteria to determine more accurate estimates
of the disease prevalence and burden. Sarcopenic obesity is
the presence of obesity when sarcopenia has been diagnosed.
Accordingly, there are two processes that need to be optimized
and standardized across populations, firstly the diagnostic
criteria for sarcopenia and secondly the classification of obesity.
Sarcopenia is a musculoskeletal disease that encompasses a range
of diagnostic criteria (28–35). The first definition of sarcopenia
was published in 1989, with the main criteria being age-related
loss of muscle mass (29). The criteria have since been expanded to
include a loss of physical function measured as grip strength and
gait speed, with the cut-offs adapted for different populations.
Different criteria include the European Working Group on
Sarcopenia (EWGSOP) (30), EWGSOP2 (31), Asian Working
Group for Sarcopenia (AWGS) (32), International Working
Group for Sarcopenia (IWGS) (34), and the Foundation for the
National Institutes of Health (FNIH) criteria (35). More locally,
Kruger et al. have suggested ethnic-specific cut-points for use in
classifying low appendicular skeletal muscle mass index in black
South African women (36). Each criterion defines sarcopenia
using muscle mass and muscle function indices; however, the
diagnostic cut-off values and diagnostic process differs. All these
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factors have led to variability and inconsistency in reporting the
prevalence of sarcopenia, especially in many LMICs where clear
diagnostic criteria have not been validated across the diverse
populations. A recent assessment of sarcopenia in a Gambian
cohort reported that the estimated population prevalence varied
according to the criteria applied (37). Specifically, when applying
the EWGSOP criteria there was a prevalence of 19% in women
and 10% in men, compared to 45% in women and 20% in men
when applying the FNIH criteria (37). More, recently, the AWGS
presented a clear strategy for the diagnosis and treatment of
sarcopenia, with different criteria that can be applied in resource-
limited community settings and health care or clinical research
settings (32). This is an approach that has been validated across
high-income countries (HIC) and LMIC Asian communities, but
a similar strategy needs to be implemented to determine whether
these criteria can be used across Africa.
The FNIH are the only criteria that incorporate body weight
into the sarcopenia criteria as they provide an adjustment for
BMI (35). Increased load bearing in obese individuals can lead to
greater absolute muscle strength and muscle mass, compared to
individuals without obesity (38). However, when muscle strength
and muscle mass are normalized to fat mass (i.e., lean to fat
mass ratio), obese individuals appear to be weaker and have
relatively less muscle (39). We hypothesize that the prevalence of
sarcopenia will continually be substantially underestimated until
population-specific cut-points (both adjusted and unadjusted for
adiposity) are developed to accurately identify low muscle mass
and muscle function; similar to that provided by the FNIH. This
stems from our recently published data (40) which reported
that older South African women (n = 122; 60–85 years) from a
low-income setting have 3.3% prevalence of sarcopenia without
obesity and 24.6% with sarcopenic obesity. We used the BMI
adjusted FNIH criteria to firstly diagnose sarcopenia, and the
World Health Organization defined categories of BMI to identify
obesity. Notably, in this same cohort we reported 4.9, 3.3,
1.6, and 0% with sarcopenic obesity when applying EWGSOP,
EWGSOP2, AWGS, and IWGS, respectively. Furthermore, the
methods used to classify obesity vary between studies and
usually include BMI, fat mass, visceral adipose tissue (%), lean
to fat mass ratio and/or waist circumference (41). We suggest
that a simple and cost-effective measure such as population-
specific BMI cut-points for obesity will suffice in low-income
communities. An additional measure of population-specific
waist circumference cut-points for central obesity may also be
considered. Due to the lack of available literature, Europid cut-
points for BMI and waist circumference are used in African
populations, with more population specific cut-points needed
(42–44). Without a consensus on the diagnostic criteria, it is
impossible to accurately measure the prevalence and estimated
burden of sarcopenic obesity in Africa. We further suggest that
group and country-specific cut-points and diagnostic processes
for sarcopenic obesity are needed to avoid additional variability
in the classification and reporting prevalence of the disease.
Importantly, the criteria should also include both gold-standard
measures that can be used in more advanced health care systems
and surrogate measures that can be used in low-income settings
with limited resources and funding, which is an approach
currently being led by the AWGS (32).
DISCUSSION/CONCLUSION
The increasing aging population in Africa, together with the
challenges of food insecurity and poverty-associated nutrient
deficiencies are associated with an increased risk of sarcopenia.
Adding to this, the increasing prevalence of obesity places
these populations at risk of sarcopenic obesity, and associated
risk of overall mortality, co-morbidities, and reduced quality
of life. A clear population-specific approach to the diagnostic
criteria, treatment and prevention for sarcopenia and sarcopenic
obesity is needed to ensure the burden on the health care
system and quality of life is not compromised further. Once the
prevalence and burden of sarcopenic obesity is established in
Africa, there will be a need to develop appropriate and sustainable
interventions that target improved dietary and physical activity
behaviors throughout the life course.
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